{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:07:31Z","timestamp":1787666851283,"version":"build-2736575974"},"reference-count":22,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1185\/030079906x167345","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T05:38:48Z","timestamp":1169703528000},"page":"417-426","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population"],"prefix":"10.1185","volume":"23","author":[{"given":"Manan","family":"Shah","sequence":"first","affiliation":[{"name":"Xcenda (formerly Applied Health Outcomes), Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Butler","sequence":"additional","affiliation":[{"name":"Xcenda (formerly Applied Health Outcomes), Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bramley","sequence":"additional","affiliation":[{"name":"Xcenda (formerly Applied Health Outcomes), Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy G.","family":"Curtice","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Fine","sequence":"additional","affiliation":[{"name":"Christ Hospital, Jersey City, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2007,1,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)49698-4"},{"key":"CIT0002","unstructured":"American Heart Association. Heart disease and stroke statistics \u2013 2005 update. Dallas (TX): American Heart Association; 2005"},{"key":"CIT0003","first-page":"7","volume":"168","author":"Boyle P","year":"1995","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1159\/000052285"},{"key":"CIT0005","first-page":"1256","volume":"173","author":"Wei JT","year":"2005","journal-title":"Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol"},{"key":"CIT0006","first-page":"1549","volume":"148","author":"Barry MJ","year":"1992","journal-title":"The American Urological Association symptom index for benign prostatic hyperplasia [The Measurement Committee of the American Urological Association]. J Urol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35405-8"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000158443.13918.d6"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000152318.79184.6f"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000139995.85780.d8"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.5.383.35053"},{"key":"CIT0012","first-page":"118","volume":"9","author":"Dang DK","year":"1996","journal-title":"Portnoy MA. Episode treatment groups: an illness classification and episode building system \u2013 part I. Med Interface"},{"key":"CIT0013","first-page":"122","volume":"9","author":"Dang DK","year":"1996","journal-title":"Portnoy MA. Episode treatment groups: an illness classification and episode building system \u2013 part II. Med Interface"},{"key":"CIT0014","unstructured":"Department of Labor, Bureau of Labor Statistics. Available at www.bls.gov [accessed January 2006]"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2003.00707.x"},{"key":"CIT0016","first-page":"13","volume":"74","author":"Pool JL","year":"1994","journal-title":"Br J Clin Pract Suppl"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1159\/000052284"},{"key":"CIT0018","first-page":"1967","volume":"283","author":"Research ALLHAT Collaborative","year":"2000","journal-title":"Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Am Med Assoc"},{"key":"#cr-split#-CIT0019.1","unstructured":"AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003)"},{"key":"#cr-split#-CIT0019.2","doi-asserted-by":"crossref","unstructured":"chapter 1: diagnosis and treatment recommendations. J Urol 2003;170: 530-47","DOI":"10.1097\/01.ju.0000078083.38675.79"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00966.x"},{"key":"CIT0021","first-page":"640","volume":"40","author":"Lloyd-Jones DM","year":"2002","journal-title":"al. Treatment and control of hypertension in the community: a prospective analysis. Hypertension"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X167345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T03:03:00Z","timestamp":1628391780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X167345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["10.1185\/030079906X167345"],"URL":"https:\/\/doi.org\/10.1185\/030079906x167345","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,23]]}}}